Effects of perioperative dextrose infusion on preventing postoperative nausea and vomiting in patients undergoing laparoscopic surgery: a meta-analysis of randomized controlled trials

Abstract

Objective

The aim of this study was to systematically examine the literature and assess the effects of perioperative dextrose infusion on the prevention of postoperative nausea and vomiting (PONV) in patients following laparoscopic surgery under general anesthesia.

Methods

We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs). Studies were eligible for inclusion if they evaluated the prevention of PONV with perioperative intravenous dextrose. Studies listed in PUBMED, Web of Science, and EMBASE databases published up to December 2020 were identified. Data were extracted and analyzed independently using a fixed-effects or random-effects model according to the heterogeneity.

Results

Six RCTs involving 526 patients were included. Our results showed that perioperative dextrose infusion not only reduced the incidence of PONV (risk ratio [RR] = 0.61, 95% confidence interval [CI]: 0.39–0.95; I² = 59%) but also decreased the requirement for antiemetics compared with the control (RR = 0.53, 95% CI: 0.42–0.66; I² = 32%). Furthermore, perioperative glucose infusion did not increase blood glucose levels compared with the control (mean difference [95% CI] = 74.55 [−20.64 to 169.73] mg/dL; I² = 100%).

Conclusion

Our study reveals that perioperative dextrose infusion may reduce the risk of PONV after laparoscopic surgery. However, additional population-based RCTs are needed to confirm this finding.

Keywords

Dextrose general anesthesia laparoscopic surgery postoperative nausea and vomiting prophylaxis randomized control trial

Introduction

The implementation of laparoscopic techniques has increased in recent decades¹ because they are associated with less postoperative pain and morbidity, a reduced length of hospital stay, and a faster recovery^2,3 compared with laparotomy. However, several studies have shown that patients who undergo laparoscopic surgery under general anesthesia are notably susceptible to post-operative nausea and vomiting (PONV) because abdominal gas insufflation may stimulate mechanoreceptors in the intestine, leading to serotonin release and consequent activation of 5-HT3 receptors.^4–6 PONV not only increases patient physical and psychological dissatisfaction, but it may also increase the risk of undesirable adverse effects, such as dehydration, electrolyte imbalance, bleeding, and surgical wound disruption, which leads to prolonged recovery, life-threatening aspiration, delayed hospital stays, and increased medical care costs.^7,8 Despite great advances in antiemetic strategies, PONV continues to be a frequent and distressing postoperative complication after anesthesia and surgery.^9,10 Therefore, treating and preventing PONV is critical to improve patient safety, accelerate postoperative recovery, reduce medical costs, and increase patient satisfaction.^8,11

Currently, a variety of antiemetic drugs are used to control PONV, including antihistamines, serotonin 5-HT3 receptor antagonists, dopamine antagonists, steroids, or droperidol.^12–14 However, these agents cause adverse reactions, such as hallucinations, headache, restlessness, dry mouth, extrapyramidal symptoms, excessive sedation, hypotension, and dystonic effects, and increase treatment costs.^15,16 Recently published evidence suggests that perioperative dextrose infusion may control PONV, but its efficacy remains debatable.^17–19 Therefore, this meta-analysis systematically assessed the effects of perioperative dextrose infusion on preventing PONV in patients after laparoscopic surgery under general anesthesia. We hope the results will increase awareness and provide suggestions for surgeons and anesthesiologists to make better treatment plans in the future.

Materials and methods

Literature retrieval strategy

A systematic literature retrieval strategy was implemented by two independent reviewers (RD and WL) using the Web of Science, Google Scholar, PubMed, and EMBASE databases from the date of their inception to 10 November 2020. Only studies reported in English were considered. The following key words were used to screen all potentially related studies: “postoperative nausea and vomiting”, “nausea”, “vomiting”, “PONV”, “dextrose”, “carbohydrate solution”, “randomized controlled trial”, and “RCT.” A manual search was performed by screening the references listed in all identified studies for additional studies. Ethical approval and informed patient consent were not applicable because this was a meta-analysis.

Inclusion and exclusion criteria

The relevant studies were included according to the following criteria: (1) intervention with perioperative dextrose infusion and control; (2) a randomized controlled trial (RCT) design; (3) laparoscopic surgery under general anesthesia; and (4) main results included the incidence of PONV, need for rescue antiemetic therapies, and postoperative blood glucose levels. The exclusion criteria were (1) non-clinical trials; (2) incomplete data; or (3) case reports, reviews, letters, or conference abstracts.

Data extraction and quality evaluation

The relevant data were independently collected from the included studies by two authors (RD and GH), including the publication year, country, first author name, interventions, sample size, and main outcomes. A quality assessment of the included articles was carried out by two reviewers (RD and XL) according to the Cochrane Handbook for Systematic Reviews of Interventions. The following items were included to evaluate the risk of bias within individual studies: random sequence generation, allocation concealment, blinding, incomplete outcome data, and free of selective reporting and other biases. When necessary, all contradictions were solved by consulting a third reviewer (XL).

Statistical analysis

All statistical analyses were performed using Review Manager (RevMan) Version 5.3 (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). Dichotomous data were expressed as the risk ratio (RR) with 95% confidence intervals (CIs). Furthermore, continuous results were presented as mean differences (MDs) with 95% CIs. The meta-analysis was conducted according to the Mantel–Haenszel method with a fixed-effects model or random-effects model based on heterogeneity. Heterogeneity across studies was assessed using I² statistics and Chi-square tests. When P < 0.05 and I² < 50%, the fixed-effects model was used for the analysis. Otherwise, the random-effects model was applied. Funnel plots were used to evaluate publication bias. P < 0.05 was considered statistically significant.

Results

Study characteristics and quality assessment

The flowchart of the literature inclusion process and results are presented in Figure 1. Initially, 245 published articles were selected after removing duplicates from 362 studies identified in the electronic databases. Then, 227 apparently irrelevant articles were excluded after screening titles and abstracts. The remaining 18 full-text studies were reviewed carefully, and an additional 12 articles were excluded for the reasons described in Figure 1. Finally, six eligible studies^17,20–24 involving 526 patients were included in this meta-analysis. The basic features of each article are shown in Table 1. Furthermore, the risk of bias in all studies according to the authors’ assessment is presented in Table 2.

Figure 1.

Flow diagram of the selection of randomized controlled trials for inclusion in the meta-analysis.

Table 1.

Characteristics of the studies included in the review.

First author (Year)	Country	Time of administration	Type of surgery	Maintenance anesthetic	Dose of dextrose	Volume of dextrose	Mean age (years)	Proportion of female patients (%)	Patients (n)		Outcomes included in the meta-analysis
First author (Year)	Country	Time of administration	Type of surgery	Maintenance anesthetic	Dose of dextrose	Volume of dextrose	Mean age (years)	Proportion of female patients (%)	Control	Dextrose	Outcomes included in the meta-analysis
Atashkhoei (2018)	Iran	5 min before the induction of anesthesia	Diagnostic gynecologic laparoscopy	Propofol	500 mg/kg	10 mL/kg/h	32.1 (1.0)	70/70 (100%)	35	35	Incidence of PONV, Requirement for antiemetics, Glucose level
Rao (2017)	India	At the PACU	Laparoscopic cholecystectomy	Isoflurane	50 g	1000 mL	43 (13)	94/115 (51.1%)	59	56	Incidence of PONV, Requirement for antiemetics, Glucose level
Firouzian (2017)	Iran	30 minutes before induction of anesthesia	Laparoscopic cholecystectomy	Isoflurane and nitrous oxide	25 g	500 mL	41.4 (12.8)	121/121 (100%)	60	61	Requirement for antiemetics, Glucose level
Mishra (2017)	India	Continuously during gallbladder removal	Laparoscopic cholecystectomy	Isoflurane	12.5 g	250 mL	39.6 (11.5)	75/100 (75%)	50	50	Incidence of PONV, Requirement for antiemetics
Conan McCau (2003)	USA	At the induction of anesthesia	Elective gynecologic laparoscopy	Sevoflurane	32 ± 5.8 g	1148 ± 210 mL	32.3 (5.0)	71/71 (100%)	36	35	Incidence of PONV
Cook (1990)	Australia	Intraoperative	Laparoscopic examination of pelvic viscera	Enflurane 1% and nitrous oxide	1 g/kg	20 mL/kg	31.4 (6.5)	49/49 (100%)	24	25	Requirement for antiemetics

PACU: post-anesthesia care unit; PONV: postoperative nausea and vomiting.

Table 2.

Quality assessment of the included studies.

Author (year)	Random sequence generation	Allocation concealment	Blinding of participants and personnel	Blinding of outcome assessment	Incomplete outcome data	Selective reporting	Other bias
Atashkhoei (2018)	Yes	Yes	Yes	No	Unclear	No	Unclear
Rao (2017)	Yes	Yes	Yes	Yes	Yes	No	Unclear
Firouzian (2017)	Yes	Yes	Yes	Yes	No	No	Unclear
Mishra (2017)	Yes	Yes	Yes	Yes	Yes	No	Unclear
Conan McCau (2003)	Yes	Yes	Yes	Unclear	No	No	Unclear
Cook (1990)	Yes	Yes	No	No	Yes	No	Unclear

Incidence of PONV

As shown in Figure 2, four RCTs^17,20,22,24 with 356 patients reported perioperative dextrose administration and the incidence of PONV following laparoscopic surgery under general anesthesia. Compared with the control group, there was a statistically significant reduction in the incidence of PONV in the dextrose group (RR = 0.61, 95% CI: 0.39–0.95; I² = 59%; P = 0.03), which was pooled according to the random-effects model because of the high heterogeneity of the included studies (Figure 2).

Figure 2.

Forest plots and meta-analysis of PONV.

Requirement for antiemetics

As shown in Figure 3, there were five studies^{17,20,21,23,24} involving 455 patients that reported the use of antiemetic drugs (228 in the control group and 227 in the dextrose group). Compared with the control group, the pooled analysis of these studies via a fixed-effects model showed there was a statistically significant reduction in the use of antiemetic drugs in the dextrose group (RR = 0.53, 95% CI: 0.42–0.66; I² = 32%; P < 0.00001) (Figure 3).

Figure 3.

Forest plots and meta-analysis of the requirement for antiemetics.

Glucose levels

Three included studies^20,23,24 with 306 patients reported the side effects (glucose level) after dextrose infusion. Compared with the control group, the results of our meta-analysis indicated that perioperative dextrose administration did not increase blood glucose levels (MD [95% CI] = 74.55 [−20.64–169.73] mg/dL), which was pooled according to the random-effects model because of the substantial heterogeneity (I² = 100%) (Figure 4).

Figure 4.

Forest plots and meta-analysis of glucose levels.

Publication bias and sensitivity analysis

A funnel plot was used to qualitatively evaluate publication bias (Figure 5). The shape of the funnel plot was partially symmetrical, indicating no significant evidence of asymmetry and no obvious evidence of publication bias. The sensitivity was evaluated, and the exclusion of any study did not impact the pooled estimates of RRs, indicating the reliability and stability of the results.

Figure 5.

Funnel plot for detecting publication bias in the included literature.

Discussion

Currently, PONV remains a significant complication in clinical practices under general anesthesia, especially laparoscopic surgery.²⁵ Abdominal gas infusion may stimulate mechanoreceptors of the gastrointestinal tract, resulting in the release of serotonin and the consequent activation of 5-HT3 receptors.²⁶ As a result, patients undergoing laparoscopic surgery are more likely to develop PONV. Previous meta-analyses have evaluated the effects of perioperative dextrose infusion on the prevention of PONV.^27,28 However, the clinical applicability of previous meta-analyses was ambiguous because they involved different types of surgery, which led to an increased risk of bias. In our meta-analysis, we assessed the effects of perioperative glucose infusion on the prevention of PONV after laparoscopic surgery. Our results indicated that intraoperative infusion of dextrose not only reduced the incidence of PONV but also decreased the need for antiemetic drugs after general anesthesia.

The results of our study were partially consistent with those of previous meta-analyses.^27,28 Mishra et al.¹⁷ reported that intraoperative infusion of dextrose after laparoscopic surgery significantly decreased the incidence of PONV. In addition, Atashkhoei et al.²⁴ revealed that the administration of intravenous dextrose reduced the incidence and severity of PONV in patients undergoing laparoscopic surgery and rescue antiemetic treatment. Combined with these earlier studies, our results convincingly indicated that intravenous dextrose administration during laparoscopic surgery was associated with a reduction in the incidence of PONV and antiemetic requirements.

The preoperative fasting period is the prescribed time before any operation under general anesthesia, and oral liquids or solids are not allowed during this time. We considered intravenous administration a safe and efficient method to administer dextrose to surgical patients, especially those who cannot be fed orally. The intraoperative infusion of glucose dose in 4/6 included studies^20,22–24 was ≥25 g, which is equal to 500 mL of a 5% glucose solution. Our results indicated that intravenous glucose infusion did not evidently increase blood glucose levels. However, a previous study reported that ≥50 g of glucose supplementation increased blood glucose levels to >200 mg/dL after infusion.²⁰ Studies have shown that perioperative hyperglycemia increases the risk of surgical site infection.^29,30 Therefore, the volume of dextrose administered is worth further exploration.

The mechanism by which intravenous glucose improves PONV is unclear. It may be associated with a reduction in hyperglycemia-induced gastric acid secretion. Additionally, gastric contractions and nausea may be caused by increased gastric acid secretion.³¹ Studies have found that blood glucose might inhibit gastric acid secretion by regulating the vagal cholinergic pathways.^32,33 Furthermore, intraoperative infusion of glucose may contribute to postoperative insulin resistance, potentially leading to PONV.^34,35 Additionally, higher blood glucose levels increase plasma cholecystokinin, which regulates pain and anxiety through the brain to reduce pain and PONV.^36,37 Postoperative pain is a known risk factor for PONV.³⁸

Our study had some strengths. First, this analysis quantitatively evaluated the efficiency of dextrose infusion in the prevention of PONV after laparoscopic surgery under general anesthesia. Second, the methodology applied in this meta-analysis was strict because all selected studies were prospective RCTs. Third, the quality of all included studies was relatively high. Fourth, the funnel plot did not show significant evidence of asymmetry, indicating the reliability and stability of the results.

Despite these important findings, our meta-analysis has several limitations. First, our analysis involved only six RCTs, and the number of participants was relatively small. Second, subgroup analyses were not carried out due to the limited number of identified studies; therefore, the source of heterogeneity could not be determined. Third, because all RCTs were restricted to the English language, important studies reported in other languages may have been missed, thereby introducing a language bias. Fourth, we investigated relatively healthy patients undergoing laparoscopic surgery. Therefore, these results cannot be extrapolated to patients with major comorbidities or diabetes mellitus. Finally, although all selected studies were RCTs, some did not describe the randomization methods, blinding procedures, or missing data, which might have led to a high risk of publication and selection bias (Figure 5).

Our analysis suggests that perioperative dextrose infusions significantly reduce the incidence of PONV and the requirement for antiemetic drugs in patients after laparoscopic surgery. However, the above evidence needs to be further verified in large, multi-center, elegantly designed RCTs.

Footnotes

Author contributions

XL and RD conceived and designed the study. WL and RD conducted the data searches. GH and RD performed the analysis and wrote the manuscript. RD revised the manuscript. XL gave the final approval of the manuscript.

Declaration of conflicting interest

The authors declare that there is no conflict of interest.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

ORCID iD

Xiaocheng Liu

References

Taillieu

De Meyere

Nuytens

, et al. Laparoscopic liver resection for colorectal liver metastases - short- and long-term outcomes: A systematic review. World J Gastrointest Oncol 2021; 13: 732–757. doi: 10.4251/wjgo.v13.i7.732.

Fretland

ÅA

Dagenborg

Bjørnelv

GMW

, et al. Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial. Ann Surg 2018; 267: 199–207. doi:10.1097/sla.0000000000002353.

Idrees

Johnston

Canner

, et al. Cost of Major Complications After Liver Resection in the United States: Are High-volume Centers Cost-effective? Ann Surg 2019; 269, 503–510. doi:10.1097/sla.0000000000002627.

Sinclair

Chung

and Mezei

Can postoperative nausea and vomiting be predicted?

Anesthesiology 1999; 91: 109–118. doi:10.1097/00000542-199907000-00018.

Apfel

Läärä

Koivuranta

, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91, 693–700. doi:10.1097/00000542-199909000-00022.

Koivuranta

Läärä

Snåre

, et al. A survey of postoperative nausea and vomiting. Anaesthesia 1997; 52: 443–449. doi:10.1111/j.1365-2044.1997.117-az0113.x.

Cohen

Duncan

DeBoer

, et al. The postoperative interview: assessing risk factors for nausea and vomiting. Anesth Analg 1994; 78: 7–16. doi:10.1213/00000539-199401000-00004.

Stadler

Bardiau

Seidel

, et al. Difference in risk factors for postoperative nausea and vomiting. Anesthesiology 2003; 98: 46–52. doi:10.1097/00000542-200301000-00011.

Watcha

and White

PF.

Postoperative nausea and vomiting. Its etiology, treatment, and prevention.

Anesthesiology 1992. 77: 162–184. doi:10.1097/00000542-199207000-00023.

10.

Gan

Meyer

Apfel

, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97: 62–71, table of contents. doi:10.1213/01.ane.0000068580.00245.95.

11.

Tramèr

MR.

Strategies for postoperative nausea and vomiting.

Best Pract Res Clin Anaesthesiol 2004; 18: 693–701. doi:10.1016/j.bpa.2004.05.003.

12.

Horn

Wallisch

Homanics

, et al. Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting. Eur J Pharmacol 2014; 722: 55–66. doi:10.1016/j.ejphar.2013.10.037.

13.

Moon

YE.

Postoperative nausea and vomiting.

Korean J Anesthesiol 2014; 67: 164–170. doi:10.4097/kjae.2014.67.3.164.

14.

Gan

Diemunsch

Habib

, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2014; 118: 85–113. doi:10.1213/ane.0000000000000002.

15.

Kranke

and Eberhart

LH.

Possibilities and limitations in the pharmacological management of postoperative nausea and vomiting.

Eur J Anaesthesiol 2011; 28: 758–765. doi:10.1097/EJA.0b013e32834a4e1e.

16.

Ansari

Siddiqui

Haleem

, et al. Comparison of ramosetron and ondansetron for control of post-operative nausea and vomiting following laparoscopic cholecystectomy. Indian J Med Sci 2010; 64: 272–280. doi:10.4103/0019-5359.99606.

17.

Mishra

Pandey

Sharma

, et al. Is perioperative administration of 5% dextrose effective in reducing the incidence of PONV in laparoscopic cholecystectomy?: A randomized control trial. J Clin Anesth 2017; 40: 7–10. doi: 10.1016/j.jclinane.2017.03.048. Epub 2017 Apr 12.

18.

Patel

Meineke

Rasmussen

, et al. The relationship of intravenous dextrose administration during emergence from anesthesia to postoperative nausea and vomiting: a randomized controlled trial. Anesth Analg 2013; 117: 34–42. doi:10.1213/ANE.0b013e318292ed5f.

19.

Dabu-Bondoc

Vadivelu

Shimono

, et al. Intravenous dextrose administration reduces postoperative antiemetic rescue treatment requirements and postanesthesia care unit length of stay. Anesth Analg 2013; 117: 591–596. doi:10.1213/ANE.0b013e3182458f9e.

20.

Rao

Bala

Jain

, et al. Effect of intravenous dextrose administration on postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A randomised controlled trial. Eur J Anaesthesiol 2017; 34: 705–707. doi:10.1097/eja.0000000000000643.

21.

Cook

Anderson

Riseborough

, et al. Intravenous fluid load and recovery. A double-blind comparison in gynaecological patients who had day-case laparoscopy. Anaesthesia 1990; 45: 826–830. doi:10.1111/j.1365-2044.1990.tb14563.x.

22.

McCaul

Moran

O'Cronin

, et al. Intravenous fluid loading with or without supplementary dextrose does not prevent nausea, vomiting and pain after laparoscopy. Can J Anaesth 2003; 50: 440–444. doi:10.1007/bf03021053.

23.

Firouzian

Kiasari

Godazandeh

, et al. The effect of intravenous dextrose administration for prevention of post-operative nausea and vomiting after laparoscopic cholecystectomy: A double-blind, randomised controlled trial. Indian J Anaesth 2017; 61: 803–810. doi:10.4103/ija.IJA_420_16.

24.

Atashkhoei

Naghipour

Marandi

PHH

, et al. Effect of intraoperative dextrose infusion for prevention of postoperative nausea and vomiting in diagnostic gynecologic laparoscopy. Crescent J Med Biol Sci 2018; 5: 45–49. [PE: Please note for ref 24 is updated with google scholar]

25.

Aspinall

and Goodman

Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials.

BMJ 1995; 311: 844–846. doi:10.1136/bmj.311.7009.844.

26.

Gan

Risk factors for postoperative nausea and vomiting.

Anesth Analg 2006. 102: 1884–1898. doi:10.1213/01.ane.0000219597.16143.4d.

27.

Yokoyama

Mihara

Kashiwagi

, et al. Effects of intravenous dextrose on preventing postoperative nausea and vomiting: A systematic review and meta-analysis with trial sequential analysis. PLoS One 2020; 15: e0231958. doi:10.1371/journal.pone.0231958.

28.

Kim

, et al. Does perioperative intravenous dextrose reduce postoperative nausea and vomiting? A systematic review and meta-analysis. Ther Clin Risk Manag 2018; 14: 2003–2011. doi:10.2147/tcrm.s178952.

29.

Zerr

Furnary

Grunkemeier

, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63: 356–361. doi:10.1016/s0003-4975(96)01044-2.

30.

Ramos

Khalpey

Lipsitz

, et al. Relationship of perioperative hyperglycemia and postoperative infections in patients who undergo general and vascular surgery. Ann Surg 2008; 248: 585–591. doi:10.1097/SLA.0b013e31818990d1.

31.

Agarwal

Dhiraaj

Tandon

, et al. Evaluation of capsaicin ointment at the Korean hand acupressure point K-D2 for prevention of postoperative nausea and vomiting. Anaesthesia 2005; 60: 1185–1188. doi:10.1111/j.1365-2044.2005.04402.x.

32.

Loud

Holst

Rehfeld

, et al. Inhibition of gastric acid secretion in humans by glucagon during euglycemia, hyperglycemia, and hypoglycemia. Dig Dis Sci 1988; 33: 530–534. doi:10.1007/bf01798352.

33.

Lam

Masclee

De Boer

, et al. Hyperglycaemia reduces gastrin-stimulated gastric acid secretion in humans. Eur J Clin Invest 1998; 28: 826–830. doi:10.1046/j.1365-2362.1998.00362.x.

34.

Ljungqvist

Thorell

Gutniak

, et al . Glucose infusion instead of preoperative fasting reduces postoperative insulin resistance. J Am Coll Surg 1994; 178: 329–336.

35.

Ljungqvist

Nygren

and Thorell

Insulin resistance and elective surgery.

Surgery 2000; 128: 757–760. doi:10.1067/msy.2000.107166.

36.

Mitchell

Jeong

Drew

, et al. Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray. Neuropsychopharmacology 2011; 36: 1801–1810. doi:10.1038/npp.2011.59.

37.

Kissin

Bright

and Bradley

Jr.

Acute tolerance to continuously infused alfentanil: the role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems.

Anesth Analg 2000; 91: 110–116. doi:10.1097/00000539-200007000-00021.

38.

Gan

Diemunsch

Habib

, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2014; 118: 85–113. doi:10.1213/ane.0000000000000002.